(Q44288796)

English

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

scientific article published on 30 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

blastic plasmacytoid dendritic cell neoplasm

0 references

Acute myeloid dendritic cell leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

L Jeffrey Medeiros

13

object named as

L Jeffrey Medeiros

0 references

Joseph D. Khoury

14

object named as

Joseph D Khoury

0 references

Naveen Pemmaraju

7

object named as

Naveen Pemmaraju

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mark J Routbort

5

object named as

Mark J Routbort

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Neelima G Reddy

6

object named as

Neelima Reddy

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sergej Konoplev

3

object named as

Sergej Konoplev

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rajyalakshmi Luthra

12

object named as

Rajyalakshmi Luthra

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Khaled Alayed

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Keyur P Patel

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Rajesh R Singh

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Liping Zhang

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Abdulaziz Al Shaikh

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Tariq N Aladily

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Nitin Jain

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

30 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1055-1061

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Gene mutations of acute myeloid leukemia in the genome era.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

The role of mutations in epigenetic regulators in myeloid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Clinical and biologic features of CD4+CD56+ malignancies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23567

21 January 2018

Identifiers

10.1002/AJH.23567

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44288796&oldid=2109172950"